Search Results for: FORM

“Yes Means Test” During Condom Awareness Month

While February is the month of love, it also serves as Condom Awareness Month, and there’s no better time to remind you to protect yourself and your partner from Sexually Transmitted Infections (STIs) by using condoms. Using condoms every time you have sex not only protects you from STIs and unwanted pregnancies, it’s also a way to […]

American Heart Month

February is American Heart Month and marks an important opportunity to empower men and women to be more mindful of their heart health, know their cardiovascular risk and take action to live longer, healthier lives. According to the American Heart Association, nearly 80 percent of cardiac events can be prevented, however cardiovascular diseases continue to […]

Final LCD for the 4Kscore Test

Have you heard the news that the final Local Coverage Determination (LCD) from the Medicare MAC for the 4Kscore® Test, Novitas, is now effective. The LCD includes defined coverage criteria from Medicare, including required documentation of Shared Decision Making prior to ordering the 4Kscore Test. Full text of the final LCD can be found here. […]

BioReference Laboratories Showcases 2019 Growth through the Addition of Cutting Edge Tests, Greater Access to Services, and Optimized Patient Experience

Press Release Quote

ELMWOOD PARK, N.J., December 19, 2019 – BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, Inc., and oncology, urology and women’s health division, GenPath Diagnostics, are pleased to provide a 2019 business update, highlighting new tests that lead to faster diagnoses, payer relationships that provide greater access to […]

Novitas Issues Final Local Coverage Determination for the 4Kscore® Test

Medicare coverage for patients meeting certain criteria to begin as of December 30, 2019 MIAMI, Nov. 15, 2019 (GLOBE NEWSWIRE) — OPKO Health, Inc. (OPK) today announced that Novitas Solutions, Inc. has issued its final Local Coverage Determination (LCD) for Medicare payments for the 4Kscore® test with defined coverage criteria, effective December 30, 2019.  Full text of the […]

Seasonal Influenza

Additional Resources

Notice of Privacy Practices

Newsletter

Newsletter Fill out the form below to receive BioReference’s latest updates and news. *By submitting this form, you are agreeing to receive Marketing Information from BioReference Laboratories, or one of its subsidiaries.

BioReference Laboratories Selected as Preferred Laboratory Provider by The IPA Association Of America

BioReference to Provide Diagnostic Test Services and Assist with Patient-Centered Data Analytics ELMWOOD PARK, NJ. (August 1, 2019) – BioReference Laboratories, Inc., one of the largest clinical laboratories in the United States, today announced it has been selected by The IPA Association of America (TIPAAA) as its preferred provider of laboratory services and to assist with data […]